Skip navigation

Robin Bellas
Special Partner

Robin is a Special Partner of Lightstone Ventures in Palo Alto and a General Partner of Morgenthaler Ventures, having recently served as Morgenthaler’s Managing Partner where he led the Firm’s transformation to a performance-based compensation and leadership meritocracy. Robin joined Morgenthaler after ten years as an operating executive in the life science industry and has directed the exits of over 20 Morgenthaler companies with a combined value of $10 billion.

Robin formed Morgenthaler’s Life Science team and initially incubated medical device companies IVS and Ensure Medical, followed by The Foundry and ForSight Labs. He invested in and served as a Director of Ardian, Cabochon Aesthetics, and Miramar, as well as Transcend, ForSight Vision2, Nexis Vision, ForSight Vision4, and ForSight Vision5. Robin led Morgenthaler’s venture financings in Ardian at The Foundry and served as a Director of the company. In 2011, Medtronic completed the acquisition of Ardian for $800 million plus uncapped annual revenue growth milestones through 2015.

Robin’s additional exits include Arbor Health Care (AHCC) (acquired by Extendicare), Athena Neurosciences (ATHN) (acquired by Elan), CardioThoracic Systems (CTSI) (acquired by Guidant), CareMedic Systems (acquired by UnitedHealth), Embol-X (acquired by Edwards), Ensure Medical (acquired by J&J), Executone (XTON), ForSight Vision2 (acquired by QLT), Integrated Vascular Systems (acquired by Abbott Labs), IPC The Hospitalist Company (IPCM), The Liposome Company (LIPO) (acquired by Élan), Managed Health Network (acquired by Foundation Health), Medaphis (MEDA) (acquired by Per-Se), National Medical Diagnostics (acquired by GE Medical), Perclose (PERC) (acquired by Abbott Labs), Sequana Therapeutics (SQNA) (acquired by Arris Pharmaceuticals), Surgical Health (acquired by HealthSouth), Verifone (VFIC) (acquired by Hewlett Packard), Vical (VICL) and Xtent (XTNT) (acquired by Biosensors).

Robin is a past Director of the Western Association of Venture Capitalists (WAVC) and the Stanford Business School Trust, and is currently a director of the U.S. Naval Academy Foundation. Before Stanford, Robin served on nuclear fast attack and ballistic missile submarines. He received a BS in Engineering from the United States Naval Academy, is a two-time National Champion in Heavyweight Crew, and has an MBA from the Stanford Graduate School of Business.


B.S. in Engineering from the United States Naval Academy
M.B.A. from Stanford Graduate School of Business